State Street
ACXP icon

State Street’s Acurx Pharmaceuticals ACXP Stock Holding History

State Street’s Portfolio ACXP Stock Details ACXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,173
Closed -$22.2K – 4284
2025
Q2 		$22.2K Hold
2,173
– – ﹤0.01% 4191
2025
Q1 		$17K Hold
2,173
– – ﹤0.01% 4224
2024
Q4 		$35.4K Hold
2,173
– – ﹤0.01% 4162
2024
Q3 		$82.6K Hold
2,173
– – ﹤0.01% 4014
2024
Q2 		$97.8K Hold
2,173
– – ﹤0.01% 4021
2024
Q1 		$106K Buy
2,173
+745
+52% +$48.4K ﹤0.01% 4022
2023
Q4 		$109K Buy
+1,428
New +$108K ﹤0.01% 4039

Other funds holding ACXP

PFS
Prospect Financial Services Melville, New York $164M AUM 19.24% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
CPG
Cornerstone Planning Group Fairfield, New Jersey $749M AUM 17.97% 1-Year Est. Return
GWSG
GPS Wealth Strategies Group Centennial, Colorado $117M AUM 24.22% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

State Street's ACXP Position: Q3 2025 in Review

State Street sold out of Acurx Pharmaceuticals (ACXP) in Q3 2025, closing a stake of 2,173 shares — an estimated $22.2K sold.

State Street first reported a position in ACXP in Q4 2023 and held it in 7 quarters. The position peaked at $109K in Q4 2023. 16 funds tracked by Wall St. Rank hold ACXP as of Q3 2025.

  • State Street reported no remaining Acurx Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • State Street sold 2,173 Acurx Pharmaceuticals shares in Q3 2025, an estimated $22.2K.
  • State Street first reported a position in Acurx Pharmaceuticals in Q4 2023 and held it in 7 quarters.
  • State Street's Acurx Pharmaceuticals position peaked at $109K in Q4 2023.
  • 16 funds tracked by Wall St. Rank held Acurx Pharmaceuticals as of Q3 2025.

Based on State Street's 13F filing for Q3 2025, filed 14 Nov 2025.